LIP
INDV icon

Liontrust Investment Partners’s Indivior Pharmaceuticals INDV Stock Holding History

Liontrust Investment Partners’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,326,647
Closed -$17M – 244
2024
Q4 		$17M Sell
1,326,647
-42,627
-3% -$439K 0.25% 71
2024
Q3 		$21.5M Hold
1,369,274
– – 0.3% 65
2024
Q2 		$21.5M Sell
1,369,274
-8,617
-0.6% -$156K 0.3% 65
2024
Q1 		$23.3M Sell
1,377,891
-109,586
-7% -$2.06M 0.33% 57
2023
Q4 		$22.5M Sell
1,487,477
-508,412
-25% -$9.03M 0.33% 56
2023
Q3 		$43.3M Buy
+1,995,889
New +$45.5M 0.69% 37

Other funds holding INDV

TSC
Two Seas Capital Rye, New York $2.17B AUM 169.27% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $5.91B AUM 42.97% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return